Yaqrit Overview
- Founded
-
2001
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
5
Yaqrit General Information
Description
Operator of a clinical-stage life sciences company intended to develop end-to-end applications to prevent, treat and reverse advanced liver disease. The company integrates technical expertise, clinical trial design and execution with its global collaborator network to accelerate the development of the programs for severely ill patients with cirrhosis or Acute-on-Chronic Liver Failure (ACLF) to include patients with the complication of cirrhosis, Non-Alcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD), which affects a significant proportion of the population in developed economies, enabling to deliver clinical and commercial success.
Contact Information
Website
www.yaqrit.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
- The Elms Courtyard Bromesberrow
- Ledbury HR8 1RZ
- England, United Kingdom
Yaqrit Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Yaqrit Patents
Yaqrit Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201013785-D0 | Treatment | Ceased | 17-Aug-2010 | 000000000 | |
| ES-2700783-T3 | Treatment | Active | 17-Aug-2010 | 000000000 | |
| US-10639346-B2 | Treating hyperammonemia, reducing plasma ammonia with tlr4 antagonists | Active | 17-Aug-2010 | 000000000 | 0 |
| US-20180256669-A1 | Treating renal and liver dysfunction with tlr4 antagonists | Granted | 17-Aug-2010 | 000000000 | 0 |
| US-9889176-B2 | Treating renal and liver dysfunction with tlr4 antagonists | Active | 17-Aug-2010 | A61K38/10 | 0 |
Yaqrit Executive Team (5)
Yaqrit Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000 | Yaqrit | Chief Executive Officer & Board Member | 000 0000 |
| 00000 0000000 00 | Yaqrit | Board Member | 000 0000 |
| 0000 0000000 | Self | Board Member | 000 0000 |
| 0000000 00000 | Yaqrit | Chief Financial Officer & Board Member | 000 0000 |
| 0000000 000000 | Yaqrit | Board Member | 000 0000 |
Yaqrit Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Yaqrit Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|